• Je něco špatně v tomto záznamu ?

Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli

I Frydrych, P Mlejnek

. 2008 ; 105 (6) : 1501-1506.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11006241
E-zdroje

NLK Wiley Online Library (archiv) od 1996-01-01 do 2012-12-31

We recently demonstrated that TLCK and TPCK could act as potent but nonspecific inhibitors of mature caspases [Frydrych and Mlejnek [2008] J Cell Biochem 103:1646-1656]. The question whether TLCK and TPCK inhibit simultaneously caspase activation and/or processing remained, however, open. In this article, we demonstrated that TPCK even enhanced caspase-3 and caspase-7 processing although it substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity in HL-60 cells exposed to various cell death inducing stimuli. Under the same conditions, TLCK had no effect or affected caspase-3 and caspase-7 processing marginally depending on cell treatment used. Importantly, TLCK substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity irrespectively to the treatment used. Interestingly, treatment of cells with toxic concentrations of TPCK alone was accompanied by full caspase-3 and -7 processing even if it induced necrosis. In contrast, treatment of cells with concentrations of TLCK that caused necrosis was accompanied by only partial caspase-3 and caspase-7 processing. Our results clearly indicated that TPCK and TLCK did not inhibit caspase-3 and -7 enzymatic activity by prevention of their activation and/or processing.

000      
02819naa 2200337 a 4500
001      
bmc11006241
003      
CZ-PrNML
005      
20121112124307.0
008      
110401s2008 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Frydrych, Ivo $7 xx0169396
245    10
$a Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli / $c I Frydrych, P Mlejnek
314    __
$a Faculty of Medicine and Dentistry, Department of Biology, Palacky University Olomouc, Hnevotinska 3, Olomouc 77515, Czech Republic.
520    9_
$a We recently demonstrated that TLCK and TPCK could act as potent but nonspecific inhibitors of mature caspases [Frydrych and Mlejnek [2008] J Cell Biochem 103:1646-1656]. The question whether TLCK and TPCK inhibit simultaneously caspase activation and/or processing remained, however, open. In this article, we demonstrated that TPCK even enhanced caspase-3 and caspase-7 processing although it substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity in HL-60 cells exposed to various cell death inducing stimuli. Under the same conditions, TLCK had no effect or affected caspase-3 and caspase-7 processing marginally depending on cell treatment used. Importantly, TLCK substantially inhibited caspase-3 and caspase-7 enzymatic (DEVDase) activity irrespectively to the treatment used. Interestingly, treatment of cells with toxic concentrations of TPCK alone was accompanied by full caspase-3 and -7 processing even if it induced necrosis. In contrast, treatment of cells with concentrations of TLCK that caused necrosis was accompanied by only partial caspase-3 and caspase-7 processing. Our results clearly indicated that TPCK and TLCK did not inhibit caspase-3 and -7 enzymatic activity by prevention of their activation and/or processing.
590    __
$a bohemika - dle Pubmed
650    _2
$a apoptóza $7 D017209
650    _2
$a kaspasa 3 $x metabolismus $7 D053148
650    _2
$a kaspasa 7 $x metabolismus $7 D053179
650    _2
$a HL-60 buňky $7 D018922
650    _2
$a lidé $7 D006801
650    _2
$a inhibitory serinových proteinas $x farmakologie $7 D015842
650    _2
$a tosyllysinchlormethylketon $x farmakologie $7 D014107
650    _2
$a tosylfenylalanylchlormethylketon $x farmakologie $7 D014108
650    _2
$a inhibitory kaspas $7 D061945
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mlejnek, Petr, $d 1963- $7 xx0023808
773    0_
$t Journal of Cellular Biochemistry $w MED00002577 $g Roč. 105, č. 6 (2008), s. 1501-1506
910    __
$a ABA008 $b B 1700 $y 2
990    __
$a 20110414102644 $b ABA008
991    __
$a 20121112124321 $b ABA008
999    __
$a ok $b bmc $g 833848 $s 698333
BAS    __
$a 3
BMC    __
$a 2008 $x MED00002577 $b 105 $c 6 $d 1501-1506 $m Journal of cellular biochemistry $n J Cell Biochem
LZP    __
$a 2011-1B09/dkjp

Najít záznam